Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02766582
Title Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cleveland Clinic Cleveland Ohio United States Details
Medical College of Wisconsin and Froedtert Hospital Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field